THE COSTS OF INOCULATING CHILDREN AGAINST COVID-19 FAR OUTWEIGH THE BENEFITS
Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Free to Read and Share without paying In our Toxicology Reports (TR) paper on COVID-19 that examined myriad issues associated with the ongoing mass inoculations (hereafter called the TR paper), we also evaluated the ratio of costs to benefits (relative to deaths) for what we termed a best-case scenario.
